BASF and Evolva enter into a collaboration to develop compounds applied to protect crops
“The collaboration with Evolva underlines BASF’s approach to employ cutting edge biotechnology for the development of new specialty products,” said Harald Lauke, President of the Specialty Chemicals Research at BASF.
The collaboration will initially cover two projects. BASF will pay Evolva an up-front technology access fee and ongoing research fees. BASF will have responsibility to take forward compounds produced during the collaboration and will potentially pay Evolva research and development milestone fees as well as royalties on products that result from the collaboration.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.